--- title: "Tmall Medical Beauty fired the first shot at Meituan" description: "Meituan's medical beauty landscape is facing the most intense \"low-price airstrike\" from e-commerce giant Alibaba. On January 21, Xinfeng noticed that on Tmall Medical Beauty's \"Hundred" type: "news" locale: "en" url: "https://longbridge.com/en/news/273258331.md" published_at: "2026-01-21T16:14:25.000Z" --- # Tmall Medical Beauty fired the first shot at Meituan > Meituan's medical beauty landscape is facing the most intense "low-price airstrike" from e-commerce giant Alibaba. On January 21, Xinfeng noticed that on Tmall Medical Beauty's "Hundred Meituan's medical beauty landscape is facing the fiercest "low-price airstrike" from e-commerce giant Alibaba. On January 21, Xinfeng noticed that in the "Billion Subsidy" channel of Tmall Medical Beauty, the terminal price of "Childlike Needle" Aiweilan (84mg) has dropped to 1399 yuan per unit. If platform coupons are applied, the actual purchase price of this product can even be as low as 999 yuan. This price not only breaks the industry's bottom line but also directly challenges Meituan. In the same Beijing area, the price of Aiweilan on the Meituan platform remains around 4000 yuan. This means that Tmall is attempting to compete with Meituan for high-ticket light medical beauty users through an extreme "price-breaking" strategy. Previously, Meituan had built a strong moat with its vast offline supply. Data shows that by August 2025, Meituan's platform will have opened nearly 9,500 new medical beauty institutions this year and attracted over 200 upstream brands, demonstrating significant scale advantages. Faced with such a large existing barrier, Tmall cannot catch up with the scale of institutions in a short time and can only choose to attract users directly through subsidies. Before this, the "price war" in the childlike needle sector had already been brewing. In September last year, New Oxygen launched the "Miracle Childlike 3.0" priced at 2999 yuan, which is far lower than the average market price of 13,000 to 24,000 yuan at that time. With the increase in the number of approved injectables and the entry of internet giants, upstream manufacturers' control over channels is visibly declining. As internet giants begin to reshape medical beauty with the "billion subsidy" logic, all parties may have to get involved in this brutal price war. ### Related Stocks - [MPNGY.US - Meituan](https://longbridge.com/en/quote/MPNGY.US.md) - [00241.HK - ALI HEALTH](https://longbridge.com/en/quote/00241.HK.md) - [03690.HK - MEITUAN](https://longbridge.com/en/quote/03690.HK.md) - [09988.HK - BABA-W](https://longbridge.com/en/quote/09988.HK.md) - [ONLN.US - ProShares Online Retail](https://longbridge.com/en/quote/ONLN.US.md) - [EBIZ.US - Global X E-commerce ETF](https://longbridge.com/en/quote/EBIZ.US.md) - [BABA.US - Alibaba](https://longbridge.com/en/quote/BABA.US.md) - [KBAB.US - KraneShares 2x Long BABA Daily ETF](https://longbridge.com/en/quote/KBAB.US.md) - [BABX.US - BABA 2x Long Daily ETF - GraniteShares](https://longbridge.com/en/quote/BABX.US.md) - [XRT.US - SPDR S&P Retail ETF](https://longbridge.com/en/quote/XRT.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 阿里傳大膽加碼淘寶閃購 3 年沒虧損負擔 力爭市佔率超越美團 | 阿里巴巴（9988）計劃在淘寶閃購上加大投入，力爭在 2026 年市佔率超越美團。管理層鼓勵團隊在未來三年內不承受虧損，重點發展即時零售，特別是高客單價訂單。儘管股價一度下跌，阿里仍將繼續探索到店業務，並計劃在春節後全面推進其戰略。 | [Link](https://longbridge.com/en/news/275711000.md) | | 美團：本集團預期 2025 年度錄得虧損約人民幣 233 億元至人民幣 243 億元 | 美團預計 2025 年度將錄得虧損約人民幣 233 億元至 243 億元，而 2024 年度則錄得溢利約 358.08 億元。預期虧損主要源於核心本地商業分部的經營溢利從 2024 年的約 524.15 億元轉為 2025 年的約 68 億 | [Link](https://longbridge.com/en/news/275897016.md) | | 中國的字節跳動公司發佈了用於 “代理時代” 的豆包 2.0 人工智能模型 | 中國的字節跳動推出了 Doubao 2.0 AI 模型，這是其領先的 AI 聊天機器人的升級版，旨在保持其在市場上的地位，以應對阿里巴巴的 Qwen 等競爭對手。此次發佈恰逢農曆新年，這是一個戰略性舉措，旨在引發關注。Doubao 2.0 | [Link](https://longbridge.com/en/news/275973214.md) | | 美國移除了將阿里巴巴和百度與中國軍方關聯的名單 | 五角大樓將包括阿里巴巴和百度在內的幾家中國公司列入其第 1260H 條款名單，稱它們與中國軍方有關。然而，該文件後來從五角大樓的網站上被刪除，取而代之的是一條消息，寫着 “該文件已被撤回。” 這是一個正在發展的故事，預計會有進一步的更新 | [Link](https://longbridge.com/en/news/275920712.md) | | 消息人士表示，美國預計將阿里巴巴及其他公司列入涉嫌協助中國軍方的公司名單 | 特朗普政府即將把阿里巴巴和其他公司加入一份聲稱支持中國軍方的公司名單。此舉預計將在週五公佈，是五角大樓 1260H 名單的一部分。該名單雖然不施加正式制裁，但向供應商和政府機構傳達了美國軍方對這些公司的立場。一些公司對其被列入名單表示異議 | [Link](https://longbridge.com/en/news/275904637.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.